Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Industry Perceptions Meet FDA Reality In AdvaMed/Lewin Survey Of 81 Firms

This article was originally published in The Gray Sheet

Executive Summary

Respondents to 1AdvaMed's first "State of the Medical Technology Industry" survey are holding that "elapsed development times" associated with PMA devices are on the rise, despite FDA data showing shortened or static review times

You may also be interested in...

CDRH Medical/Scientific Hiring Is In Partial Limbo, Awaits Approps

CDRH's Office of Device Evaluation began fiscal 2003 with six fewer medical officers and three fewer scientific reviewers than in the previous year, according to the 1ODE's FY 2002 annual report

CMS Blood Billing Rules Lead To Inadequate Reimbursement – Lewin Report

Updated guidelines on properly billing CMS for blood products and services will soon be available to hospitals from the American Association of Blood Banks, the industry group announced Oct. 15

Oxford/AstraZeneca Vaccine Shows 70% Efficacy As Company Prepares Approval Filings

Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts